中国小儿急救医学
中國小兒急救醫學
중국소인급구의학
CHINESE PEDIATRIC EMERGENCY MEDICINE
2015年
5期
289-293,294
,共6页
廖琨%钱素云%曾健生%贾鑫磊%李峥%刘珺%高恒妙
廖琨%錢素雲%曾健生%賈鑫磊%李崢%劉珺%高恆妙
료곤%전소운%증건생%가흠뢰%리쟁%류군%고항묘
非人类免疫缺陷病毒感染%肺孢子菌肺炎%流行病学%风险因素%病死率%儿童
非人類免疫缺陷病毒感染%肺孢子菌肺炎%流行病學%風險因素%病死率%兒童
비인류면역결함병독감염%폐포자균폐염%류행병학%풍험인소%병사솔%인동
Non-human immunodeficiency virus infection%Pneumocystis carinii pneumonia%Epide-miology%Risk factors%Mortality%Children
目的:分析非人类免疫缺陷病毒感染( human immunodeficiency virus,HIV)儿童肺孢子菌肺炎( pneumocystis carinii pneumonia,PCP)的流行病学特征和死亡的风险因素。方法回顾性分析2006年1月1日至2012年12月31日在我院诊断为非HIV感染PCP并接受治疗的全部病例,按照预后分为存活组和非存活组,分析其流行病学特征及死亡的风险因素。结果共计16例纳入研究,存活组10例,非存活组6例。基础疾病包括恶性肿瘤5例,非恶性肿瘤11例。非存活组平均年龄大于存活组[(12.00±2.00)岁 vs.(6.65±4.32)岁,P=0.01]、机械通气比例高于存活组(6/6例 vs.4/10例, P=0.04)、PaO2/FiO2[(73.88±26.95) mmHg vs.(167.50±97.17) mmHg,1 mmHg =0.133 kPa, P=0.01]和小儿危重病例评分低于存活组[(75.67±5.72)分 vs.(86.40±8.88)分,P=0.02]。存活组和非存活组相比,性别比例、基础疾病种类、是否合并其他感染、免疫抑制剂应用时间、发病至确诊时间、发病至开始复方新诺明治疗时间、PaCO2、血WBC计数、淋巴细胞计数、CD4+细胞计数、Hb浓度和C反应蛋白无明显差异。结论非HIV感染PCP儿童死亡的风险因素包括年龄较大、需要机械通气、PaO2/FiO2降低和小儿危重病例评分降低。
目的:分析非人類免疫缺陷病毒感染( human immunodeficiency virus,HIV)兒童肺孢子菌肺炎( pneumocystis carinii pneumonia,PCP)的流行病學特徵和死亡的風險因素。方法迴顧性分析2006年1月1日至2012年12月31日在我院診斷為非HIV感染PCP併接受治療的全部病例,按照預後分為存活組和非存活組,分析其流行病學特徵及死亡的風險因素。結果共計16例納入研究,存活組10例,非存活組6例。基礎疾病包括噁性腫瘤5例,非噁性腫瘤11例。非存活組平均年齡大于存活組[(12.00±2.00)歲 vs.(6.65±4.32)歲,P=0.01]、機械通氣比例高于存活組(6/6例 vs.4/10例, P=0.04)、PaO2/FiO2[(73.88±26.95) mmHg vs.(167.50±97.17) mmHg,1 mmHg =0.133 kPa, P=0.01]和小兒危重病例評分低于存活組[(75.67±5.72)分 vs.(86.40±8.88)分,P=0.02]。存活組和非存活組相比,性彆比例、基礎疾病種類、是否閤併其他感染、免疫抑製劑應用時間、髮病至確診時間、髮病至開始複方新諾明治療時間、PaCO2、血WBC計數、淋巴細胞計數、CD4+細胞計數、Hb濃度和C反應蛋白無明顯差異。結論非HIV感染PCP兒童死亡的風險因素包括年齡較大、需要機械通氣、PaO2/FiO2降低和小兒危重病例評分降低。
목적:분석비인류면역결함병독감염( human immunodeficiency virus,HIV)인동폐포자균폐염( pneumocystis carinii pneumonia,PCP)적류행병학특정화사망적풍험인소。방법회고성분석2006년1월1일지2012년12월31일재아원진단위비HIV감염PCP병접수치료적전부병례,안조예후분위존활조화비존활조,분석기류행병학특정급사망적풍험인소。결과공계16례납입연구,존활조10례,비존활조6례。기출질병포괄악성종류5례,비악성종류11례。비존활조평균년령대우존활조[(12.00±2.00)세 vs.(6.65±4.32)세,P=0.01]、궤계통기비례고우존활조(6/6례 vs.4/10례, P=0.04)、PaO2/FiO2[(73.88±26.95) mmHg vs.(167.50±97.17) mmHg,1 mmHg =0.133 kPa, P=0.01]화소인위중병례평분저우존활조[(75.67±5.72)분 vs.(86.40±8.88)분,P=0.02]。존활조화비존활조상비,성별비례、기출질병충류、시부합병기타감염、면역억제제응용시간、발병지학진시간、발병지개시복방신낙명치료시간、PaCO2、혈WBC계수、림파세포계수、CD4+세포계수、Hb농도화C반응단백무명현차이。결론비HIV감염PCP인동사망적풍험인소포괄년령교대、수요궤계통기、PaO2/FiO2강저화소인위중병례평분강저。
Objective To analyze the epidemiologic characteristics and risk factors for mortality in non-(human immunodeficiency virus,HIV) infected children with pneumocystis carinii pneumonia(PCP). Methods The data of non-HIV infected children with PCP diagnosed in Beijing Children′s Hospital from January 1,2006 to December 31,2012 were collected. They were divided into survival and non-survival group according to the prognosis. The epidemiologic characteristics and risk factors for mortality were analyzed. Results Sixteen patients were enrolled in this study. Ten of them survived and 6 of them were non-survived. The basic diseases included malignant tumor in 5 patients and non-malignancy diseases in 11 of them. Com-pared with the survival group,the non-survival group had a higher average age [(12. 00 ± 2. 00) years vs. (6. 65 ± 4. 32)years,P=0. 01],higher ratio to need mechanical ventilation (6/6 vs. 4/10,P=0. 04),lower PaO2/FiO2[(73. 88 ±26. 95) mmHg vs. (167. 50 ± 97. 17) mmHg,1 mmHg=0. 133 kPa,P=0. 01] and lower pediatric critical illness score(75. 67 ± 5. 72 vs. 86. 40 ± 8. 88,P=0. 02). There were no differences on sex ratio,kinds of basic diseases,whether with co-infections,the time of immunosuppressant administration, the time from onset to diagnosis,the time from onset to beginning trimethoprim-sulfamethoxazole therapy, PaCO2 ,white blood cell counts,lymphocyte counts,CD4+ cell counts,C-reactive protein,and hemoglobin con-centrations between the survival and non-survival group. Conclusion A higher age, need for mechanical ventilation,lower PaO2/FiO2 and lower pediatric critical illness score were risk factors for mortality in non-HIV infected children with PCP.